Hao Zhou

Title: Hao Zhou - Innovator in Kappa Opioid Receptor Research

Introduction

Hao Zhou is a notable inventor based in Yichang, China. He has made significant contributions to the field of pharmacology, particularly in the development of kappa opioid receptor peptide agonists. His work aims to provide new methods for treating pain and other medical conditions.

Latest Patents

Hao Zhou holds 1 patent for his invention titled "Kappa opioid receptor peptide amide ligands." This patent encompasses kappa opioid receptor peptide agonists, methods for preparing these compounds, and compositions that include these agonists. The invention also outlines methods for using these agonists to treat pain and various other conditions.

Career Highlights

Throughout his career, Hao Zhou has worked with prominent companies in the pharmaceutical industry. He has been associated with Humanwell Pharmaceutical US and Yichang Humanwell Pharmaceuticals Co. Ltd. His experience in these organizations has allowed him to contribute to significant advancements in drug development.

Collaborations

Hao Zhou has collaborated with several professionals in his field, including Subo Liao and Jun Yang. These collaborations have fostered innovation and have been instrumental in the progress of his research.

Conclusion

Hao Zhou's work in developing kappa opioid receptor peptide agonists represents a vital advancement in pain management and therapeutic applications. His contributions continue to influence the pharmaceutical landscape positively.